Please login to the form below

Not currently logged in


This page shows the latest Allegro news and features for those working in and with pharma, biotech and healthcare.

Ashfield welcomes second intake of medical writers

Ashfield welcomes second intake of medical writers

Ashfield Healthcare Communications, a global healthcare communications agency part of the UDG Healthcare group, has welcomed its second intake of aspiring medical writers into its fast-track training programme Allegro. ... Ashfield aims to train up to 80

Latest news

  • Multiplying options for MS

    Gilenya. In December 2010, top-line results from the pivotal phase III ALLEGRO trial were announced, indicating that the drug met its primary endpoint of reducing annualised relapse rates in patients ... Completion of this trial is expected later in 2011.

  • MS treatment hopes

    or placebo, and the similar, two-armed (laquinimod versus placebo) ALLEGRO trial.

  • Teva begins second Phase III trial of oral MS treatment

    The BRAVO trial will run alongside the ongoing ALLEGRO trial, a similar global, double-blind study involving around 1, 000 patients.

  • Health warning

    It is an Austin Allegro system in a Ferrari world. It is fish paste sandwiches in a Pret A Manger world.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...